The Science
Peptides are short chains of amino acids — the fundamental building blocks of proteins. They occur naturally in every living organism and act as biological messengers, signaling cells to perform specific functions with remarkable precision.
Unlike larger protein molecules, peptides are small enough to interact directly with receptors and enzymes throughout the body, making them among the most targeted therapeutic agents available to modern science. The study of peptides dates to the early 1900s when Emil Fischer first described the peptide bond. Therapeutic peptide research accelerated dramatically through the 1980s and 2000s as biotechnology matured, recombinant DNA techniques improved, and solid-phase peptide synthesis (SPPS) made large-scale production feasible.
A Brief History
Vincent du Vigneaud synthesizes oxytocin — the first chemically synthesized peptide — earning the Nobel Prize in Chemistry in 1955, proving that biologically active peptides could be manufactured outside the body.
Identification of endogenous opioid peptides (endorphins, enkephalins) and gut hormones including glucagon and secretin, establishing peptides as core physiological messengers.
First recombinant peptide therapeutics approved, including human insulin and growth hormone — transforming endocrinology and chronic disease management globally.
Explosion of GnRH analogues, natriuretic peptides, and early GLP-1 research that would ultimately yield Semaglutide and reshape the treatment of metabolic disease.
Advances in synthesis purity, bioavailability, and delivery systems. Thymosin peptides, BPC-157 research, and the emergence of the secretagogue class gain significant scientific traction.
GLP-1/GIP dual and triple agonists (Tirzepatide, Retatrutide) demonstrate unprecedented metabolic efficacy. Longevity peptides including Epithalon and MOTS-c attract serious attention at the highest levels of aging science.
Why Peptides
Peptides mimic or amplify the body's own signaling molecules, acting on precise receptor targets. This reduces off-target effects compared to many traditional small-molecule drugs.
The body enzymatically breaks peptides down into their constituent amino acids — the same building blocks present in food and tissue — contributing to their generally favorable safety profiles.
The peptide pharmacopoeia spans healing, metabolic regulation, hormonal optimization, cognitive enhancement, immune modulation, longevity, and aesthetics — arguably the most versatile class of bioactive compounds in existence.
Many peptides complement each other mechanistically, enabling combination protocols — BPC-157 + TB-500 for tissue repair, or CJC-1295 + Ipamorelin for GH optimization — that exceed either compound alone.
Advances in solid-phase synthesis and recombinant production have reduced costs dramatically, enabling commercial-scale production at high purity — accelerating both research and clinical adoption.
Multiple blockbuster approvals — Ozempic, Wegovy, Mounjaro — have fundamentally elevated the entire peptide class in mainstream medicine, driving unprecedented investment and clinical pipeline activity.
Legal Landscape
Peptides occupy a rapidly evolving regulatory space that varies significantly by jurisdiction. Understanding the current framework is essential for researchers, practitioners, and procurement professionals.
A legally recognized designation permitting manufacture, sale, and purchase of compounds for laboratory and non-clinical research purposes. RUO reflects the stage of regulatory review, not the state of the science.
A growing number of peptides have received full FDA approval:
Currently in Phase II or Phase III trials:
US compounding pharmacies under 503A and 503B frameworks have historically prepared peptide formulations for patient-specific prescriptions — BPC-157, Sermorelin, Ipamorelin, and others under physician oversight. Regulatory guidance continues to evolve.
Several peptides are approved or clinically used outside the US — including Russia (Semax, Selank), Europe, and parts of Asia — while still under research classification elsewhere. The global trend is toward broader legitimization.
Retatrutide (Eli Lilly) — GLP-1/GIP/Glucagon triple agonist — showed mean body weight reduction of up to 24% over 48 weeks in Phase II. Potentially the most potent metabolic compound in the history of clinical development.
The Comprehensive Reference Guide to Modern Peptide Science
Category 01
From gut healing to tendon repair, cardiac recovery, and neuroprotection — the front line of tissue regeneration.
10 ProductsBody Protection Compound-157, derived from a gastroprotective protein in gastric juice. Among the most extensively studied healing peptides. Research covers tendon and ligament repair, gut healing (IBD, leaky gut, ulcers), muscle recovery, neurological protection, anti-inflammatory effects, and angiogenesis.
Pre-combined BPC-157 and Thymosin Beta-4 (TB-500) for synergistic tissue repair. Addresses the local healing cascade (BPC-157) and systemic tissue remodeling and anti-inflammatory pathways (TB-500).
Comprehensive triple-compound regenerative protocol combining BPC-157's gut and tendon healing, TB-500's systemic repair, and GHK-Cu's collagen synthesis and wound healing.
Naturally occurring peptide found in virtually every human and animal cell. Studied for muscle, tendon, and ligament repair; cardiac tissue recovery; neuroregeneration; hair growth stimulation; and systemic anti-inflammatory effects.
Glycine-Histidine-Lysine copper complex. Naturally found in human plasma, saliva, and urine — declines significantly with age. Extensively studied for wound healing, collagen and elastin synthesis, hair follicle stimulation, antioxidant effects, and neuroprotection.
A copper-binding tripeptide closely related to GHK-Cu. Studied for hair follicle stimulation, scalp circulation, skin regeneration, and anti-inflammatory effects. Popular in cosmetic dermatology research.
The human cathelicidin — the body's own endogenous antimicrobial peptide. Studied for broad-spectrum antimicrobial, antiviral, antifungal, and immunomodulatory properties. Also researched for wound healing and activity against bacterial biofilms.
A non-hematopoietic EPO analogue designed to activate innate repair receptors without stimulating red blood cell production. Studied for neuropathic pain, diabetic peripheral neuropathy, and tissue cytoprotection.
A mitochondria-targeting tetrapeptide that stabilizes cardiolipin on the inner mitochondrial membrane. Studied for heart failure, kidney disease, aging, oxidative stress, and mitochondrial myopathy. Currently in clinical trials for Barth syndrome and heart failure.
An octapeptide that inhibits SNARE complex formation at neuromuscular junctions, reducing micro-contractions that contribute to expression lines. Studied as a topical cosmetic anti-aging ingredient — sometimes called a 'botox alternative.'
Category 02
The fastest-moving category in medicine. From the GLP-1 revolution to triple agonists showing 24% body weight reduction.
11 ProductsA GLP-1 receptor agonist. FDA-approved as Ozempic (Type 2 diabetes) and Wegovy (obesity). The cornerstone of the modern metabolic peptide revolution. Also studied for cardiovascular protection, kidney disease, neurodegeneration, and addiction suppression.
A GLP-1/GIP dual agonist. FDA-approved as Mounjaro (Type 2 diabetes) and Zepbound (obesity). Produces greater average weight loss than Semaglutide — up to 22% of body weight. Eli Lilly's flagship metabolic compound.
'Triple G' — a GLP-1/GIP/Glucagon triple receptor agonist developed by Eli Lilly. Currently in Phase III trials. Early Phase II data showed mean weight reduction of up to 24% over 48 weeks — potentially the most potent metabolic peptide in development.
A long-acting synthetic amylin analogue by Novo Nordisk. Studied for appetite suppression, slowed gastric emptying, and weight management. In late-stage trials in combination with Semaglutide (CagriSema) as a next-generation obesity treatment.
Pre-combined formulation mirroring the CagriSema combination under Phase III development by Novo Nordisk. Combines amylin-pathway appetite regulation with GLP-1 receptor agonism for complementary metabolic effects.
A GLP-1/glucagon dual receptor agonist by Innovent Biologics. Currently in Phase III trials for obesity and Type 2 diabetes. Increases energy expenditure and fat mobilization alongside glucose regulation.
A GLP-1/glucagon dual receptor agonist by Boehringer Ingelheim. In Phase II/III trials for obesity and NASH (non-alcoholic steatohepatitis / metabolic liver disease). Particularly promising for hepatic effects.
A synthetic fragment of human growth hormone — specifically the C-terminal lipolytic domain. Studied for fat metabolism and weight loss without the growth-promoting or insulin-disrupting effects of full hGH. Has completed Phase II/III trials in Australia.
A cell-permeable activator of AMPK — the body's master energy-sensing enzyme. Studied for endurance enhancement, fat oxidation, improved insulin sensitivity, and mitochondrial biogenesis. Sometimes described as an 'exercise mimetic.'
A peptidomimetic that selectively targets and disrupts blood vessels supplying white adipose tissue, inducing apoptosis of fat cells. Studied in non-human primates as an obesity intervention. Considered a targeted experimental fat-loss compound.
A small-molecule inhibitor of NNMT — an enzyme that regulates cellular metabolism and fat storage in adipose tissue. Studied for fat cell reduction, metabolic enhancement, and NAD+ pathway activation.
Category 03
Secretagogues that work with the body's own pulsatile GH rhythms — from the gold-standard CJC/Ipamorelin stack to FDA-approved Tesamorelin.
9 ProductsA synthetic GHRH analogue. Stimulates pituitary GH release with a physiological half-life of approximately 30 minutes, producing pulsatile GH secretion. Commonly stacked with Ipamorelin to amplify GH pulse magnitude while preserving natural rhythm.
The same GHRH analogue modified with a Drug Affinity Complex (DAC) enabling albumin binding. Extends the half-life to approximately 8 days, providing sustained GH elevation rather than pulsatile release.
The classic GH secretagogue combination. CJC-1295 provides the GHRH signal while Ipamorelin supplies the GHRP signal, producing a synergistic and clean GH pulse with minimal cortisol or prolactin stimulation.
A highly selective fifth-generation GHRP. Stimulates GH release through ghrelin receptor agonism with minimal effect on cortisol, prolactin, or ACTH — making it the cleanest GH secretagogue in current research use. Studied for anti-aging, body composition, and sleep quality.
A potent synthetic ghrelin mimetic that stimulates robust GH release from the pituitary. Produces stronger GH pulses than GHRP-6 with less appetite stimulation. Studied for GH deficiency, muscle wasting, anti-aging, and body composition.
A first-generation GHRP with strong GH-releasing effects via ghrelin receptor agonism. Produces significant appetite stimulation — useful in muscle wasting or cachexia research. Also studied for gastroprotective effects.
A potent synthetic GHRP with strong GH-releasing properties and notable cardioprotective effects independent of GH secretion. Studied for GH stimulation, fat loss, muscle preservation, and cardiac tissue protection.
A GHRH analogue comprising the first 29 amino acids of endogenous GHRH. Previously FDA-approved for pediatric GH deficiency. Studied as an anti-aging tool for restoring youthful GH pulsatility. Considered one of the safest GH secretagogues.
A stabilized GHRH analogue — FDA-approved as Egrifta for HIV-associated lipodystrophy. Also studied for visceral fat reduction in non-HIV populations and cognitive function improvement in aging individuals with mild cognitive impairment.
Category 04
From telomere elongation to BDNF upregulation — compounds at the leading edge of healthspan and lifespan science.
9 ProductsA synthetic tetrapeptide (Ala-Glu-Asp-Gly) derived from the pineal gland. One of the most studied longevity peptides. Research covers telomere elongation through telomerase activation, circadian rhythm regulation, melatonin normalization, and lifespan extension in multiple species.
A thymus gland-derived peptide complex. Studied for immune system restoration in aging, endocrine regulation, and longevity. Human studies in elderly populations showed significant reductions in mortality over 6-year follow-up periods.
A peptide encoded within mitochondrial DNA — an extremely rare class of biologically active compound. Studied for metabolic regulation, insulin sensitivity, exercise performance, stress resistance, and longevity. Levels decline significantly with age.
Nicotinamide Adenine Dinucleotide. A coenzyme central to cellular energy metabolism, DNA repair, and sirtuin (longevity gene) activation. NAD+ levels decline approximately 50% between ages 40 and 60. Studied for anti-aging, neuroprotection, metabolic health, and addiction recovery support.
The body's master endogenous antioxidant tripeptide. Critical for cellular detoxification, immune function, mitochondrial health, and protection against oxidative stress. Declines with age and chronic illness. Studied for liver protection and neurodegeneration prevention.
Also a significant anti-aging compound. Plasma GHK-Cu declines from approximately 200ng/mL at age 20 to near zero by age 60, correlating with reduced tissue repair capacity and accelerated aging. See Healing category for full profile.
A synthetic heptapeptide analogue of ACTH developed in Russia. Studied for cognitive enhancement, BDNF upregulation, neuroprotection, stroke recovery, anxiety reduction, and attention improvement. Used clinically as an intranasal formulation for ischemic stroke and cognitive decline.
A synthetic analogue of tuftsin developed by the Institute of Molecular Genetics in Russia. Studied for anxiolytic (anti-anxiety) effects, cognitive enhancement, BDNF stimulation, immune modulation, and depression. Described as a 'nootropic peptide.'
A naturally occurring neuropeptide. Studied for sleep quality improvement, cortisol modulation, stress resilience, pain reduction, and LH stimulation. Research suggests roles in circadian rhythm regulation beyond sleep induction alone.
Categories 05 – 06
From FDA-approved immune therapeutics to the only FDA-approved peptide for sexual dysfunction — and the full hormonal cascade.
6 ProductsA 28-amino acid peptide derived from thymosin fraction 5. Commercially available as Zadaxin. Approved in over 35 countries for hepatitis B, hepatitis C, and as a vaccine adjuvant. Studied for immune restoration, cancer immunotherapy support, chronic infection management, and post-viral immune dysfunction.
A cyclic heptapeptide derived from Melanotan 2. FDA-approved as Vyleesi for hypoactive sexual desire disorder (HSDD) in premenopausal women — the only FDA-approved peptide for sexual dysfunction. Studied for libido enhancement in both sexes and erectile dysfunction via central melanocortin receptor activation.
A synthetic analogue of alpha-melanocyte-stimulating hormone. Studied primarily for skin tanning via melanin production stimulation and photoprotection. Research also includes potential in skin cancer prevention through increased melanin density.
A shorter, more potent cyclic analogue of alpha-MSH. Studied for skin tanning, libido enhancement, and erectile function. PT-141 (Bremelanotide) is directly derived from MT-2, accounting for its sexual effects via melanocortin system activity.
A neuropeptide that acts as the primary upstream regulator of GnRH secretion. Studied for reproductive hormone cascade initiation, testosterone and LH stimulation, fertility support, and libido. Significant research interest for hypogonadism treatment.
The endogenous 'bonding hormone' produced in the hypothalamus. Used clinically in obstetrics for decades. Also studied for social bonding, anxiety reduction, autism spectrum disorder support, appetite suppression, and wound healing.
Category 07 · 2026 Catalog
Peptide-powered formulations for growth, density, follicle support, and scalp renewal — shampoos, conditioners, serums, and ampoules.
16 ProductsShampoos & Conditioners
Copper Tripeptide-1 and Copper Tripeptide-3 alongside Biotin and Niacinamide in a sulfate-free, silicon-free base. Targets hair growth, follicle strengthening, scalp health, and breakage minimization. Lather and leave on 2 minutes.
Copper Tripeptide-1 and -3 with Biotin, Behentrimonium Methosulfate, and Niacinamide. Strengthens follicles, supports scalp health, and minimizes breakage. Leave on 5 minutes.
Copper Tripeptide-1 with Adenosine, Caffeine, Saw Palmetto, and Cyclodextrin. Targets thickness, density, and fullness. Sulfate-free and silicon-free base. Lather and leave on 2 minutes.
Copper Tripeptide-1, Saw Palmetto, Adenosine, Caffeine, and Cyclodextrin conditioner for density and fullness. Leave on 5 minutes.
Sodium C14-16 Olefin Sulfonate base with Biotin, Panthenol, Caffeine, Adenosine, Niacinamide, Copper Tripeptide-1, Lactobacillus Date Fruit Ferment, and Polyquarternium complex. Reduces split ends and increases volume.
Sodium Laureth Sulfate base with Biotin, Adenosine, Niacinamide, Caffeine, Rice Amino Acids, Lactobacillus Date Fruit Ferment, and Polyquarternium complex. Reduces split ends and increases volume.
Dimethicone-based with Adenosine, Caffeine, Niacinamide, Biotin, Panthenol, and Hexyl Nicotinate. Strengthens follicles, supports scalp vitality, minimizes breakage. MOQ pricing: $18.10 / $16.29 / $14.66.
Deep conditioning with Coconut Fruit Oil, Adenosine, Caffeine, Niacinamide, Biotin, and Panthenol. Apply to shaft and scalp, leave 2–5 minutes. Pricing: $15.93 / $14.34 / $12.90.
Copper Tripeptide-1, Sodium Hyaluronate, Polyquarternium-10 and -67, Diheptyl Succinate, and Capryloyl Glycerin. Targets scalp and strand hydration, softening, and repair. Leave on 2–5 minutes.
Serums, Tonics & Ampoules
sh-Decapeptide-63, sh-Polypeptide-148, Hexapeptide-40, Biotinyl Tripeptide-1, Acetyl Tetrapeptide-3, and Palmitoyl Tetrapeptide-20. Targets hair growth, premature grey reduction, and scalp longevity. Leave on 5–10 minutes before styling.
Copper Tripeptide-1 and -3 combined with Biotinyl Tripeptide-1 and Palmitoyl Tetrapeptide-20. Root-level follicle support, hair growth, and scalp longevity. Leave on 5–10 minutes before styling.
Copper Tripeptide-1 with sh-Decapeptide-63, sh-Polypeptide-148, Hexapeptide-40, Biotinyl Tripeptide-1, and Palmitoyl Tetrapeptide-20. Targets growth, anti-grey, and scalp longevity.
Diaminopyrimidine Oxide Oxothiazolidinecarboxylate, Acetyl Tetrapeptide-3, Myristoyl Pentapeptide-4, and Biotinyl Tripeptide-1. Focused on hair growth activation. Leave on 5–10 minutes.
Niacinamide, Hydroxyacetophenone, Saw Palmetto Fruit Extract. Targets hair growth, scalp health, split end reduction, and oil control. MOQ pricing: $13.02 / $11.72 / $10.55.
Copper Tripeptide-1, Acetyl Tetrapeptide-3, Biotinyl Tripeptide-1, Palmitoyl Tetrapeptide-20, Palmitoyl Tripeptide-8, and Decapeptide-18. For formulating and manufacturing of commercial products.
High-concentration ampoule: Palmitoyl Tripeptide-8, Copper Tripeptide-1, Acetyl Tetrapeptide-3, Biotinyl Tripeptide-1, Palmitoyl Tetrapeptide-20, Decapeptide-18. Apply small amount directly to targeted scalp areas. Leave on.
Category 08 · 2026 Catalog
Multi-peptide moisturizers, serums, eye treatments, sunscreens, and formulation bases — each built on active peptide science.
30 ProductsMoisturizers & Creams
Low-irritation retinoid technology with Squalane, Ketoglutaric Acid, Ferulic Acid, Hydroxypinacolone Retinoate, Palmitoyl Tripeptide-5, and Acetyl Hexapeptide-8. Reduces wrinkles, smooths, antioxidant. Night use.
Rich peptide panel: sh-Polypeptide-69, Palmitoyl Pentapeptide-4, Tripeptide-32, Hexapeptide-9, Acetyl Hexapeptide-8, Copper Tripeptide-1, Palmitoyl Tripeptide-5, Nonapeptide-1. Reduces fine lines, repairs barrier, tightens.
Squalane base with D-Ribose, Idebenone, Ectoin, Copper Tripeptide-1, Hexapeptide-9, and Palmitoyl Tripeptide-5. Cellular-level defense against fine lines with barrier repair and tightening.
Isododecane base with Soluble Collagen, Acetyl Hexapeptide-8, Acetyl Octapeptide-3, Palmitoyl Tripeptide-1 and -7. Enhances repair, skin elasticity, reduces inflammation, and tightens. Day and night use.
Alpha Lipoic Acid with Acetyl Octapeptide-3 in a Coco-Caprylate/Caprate and Dimethyl Isosorbide base. Antioxidant, restorative photo-aging, and brightening. Day and night.
Retinol with Palmitoyl Tripeptide-1 and -7 in a Dimethicone and Polysilicone-11 base. Anti-aging, minimizes acne, boosts collagen. Night use.
Niacinamide-forward with Palmitoyl Tripeptide-1 and -7. Brightens, reduces inflammation, and balances oil. Day and night use.
Retinal with Acetyl Octapeptide-3 in a Coco-Caprylate/Caprate and Hydroxyethyl Acrylate base. Anti-aging, minimizes acne, boosts collagen. Night use only.
Tranexamic Acid with Acetyl Hexapeptide-8. Brightens and fades melasma and hyperpigmentation. Use day and night with SPF during the day.
Sodium Hyaluronate and Copper Tripeptide-1 in Squalane and Coco-Caprylate/Caprate base. Deep hydration and plumping. Day and night use.
Extensive peptide complex including Copper Tripeptide-1, Dipeptide Diaminobutyroyl Benzylamide Diacetate, Hexapeptide-2, Palmitoyl Tripeptide-1, Palmitoyl Pentapeptide-4, Palmitoyl Tripeptide-5 and -38, Palmitoyl Tetrapeptide-7, Trifluoroacetyl Tripeptide-2. Nourishing, rejuvenating, reduces fine lines.
Ascorbic Acid (Vitamin C) with Acetyl Hexapeptide-8 in a light hydrogel base. Antioxidant, collagen-boosting, and dark spot-fading. Use day and night with SPF during the day.
Ceramide-rich (NP, AP, EOP, AS, NS) base with Pentapeptide-18, Copper Tripeptide-1, Dipeptide Diaminobutyroyl Benzylamide Diacetate, Acetyl Hexapeptide-8 and -30. Reduces muscle contraction, wrinkles, and smooths expression lines.
Serums
Comprehensive peptide panel: sh-Polypeptide-69, Acetyl Tetrapeptide-2 and -5, Palmitoyl Pentapeptide-4, Tripeptide-32, Hexapeptide-9, Acetyl Hexapeptide-8, Palmitoyl Tetrapeptide-7, Copper Tripeptide-1, Palmitoyl Tripeptide-5, Nonapeptide-1. Firms, boosts elasticity, reduces fine lines, brightens.
Copper Tripeptide-1, Nicotinamide Mononucleotides, Acetyl Hexapeptide-8, Dipeptide Diaminobutyroyl Benzylamide Diacetate, Collagen, sh-Oligopeptide-1 and -2, sh-Polypeptide-9 and -11. Restorative photo-aging and barrier repair.
DNA, Acetyl Hexapeptide-8, Acetyl Octapeptide-3, Palmitoyl Tripeptide-1 and -7 in an Acrylates Crosspolymer base. Tightens, reduces fine lines and wrinkles, and smooths.
Centella Asiatica Leaf Vesicle with Palmitoyl Tripeptide-1 and -7, Acetyl Hexapeptide-8, and Acetyl Octapeptide-3. Vegan, alcohol-free, oil-free. Tightening, fine line reduction, and smoothing.
Copper Tripeptide-1, Sodium Hyaluronate, Acetyl Hexapeptide-8 and -30, Dipeptide Diaminobutyroyl Benzylamide Diacetate, Pentapeptide-18, and Nonapeptide-1. Anti-aging and tightening focus.
Salicylic Acid with Acetyl Octapeptide-3 and Saw Palmetto Fruit Extract. Exfoliates, unclogs pores, minimizes acne. Apply to cleansed face before moisturizer, day and night.
Eye Treatments, Sunscreens & Specialty
Squalane, Hesperidin Methyl Chalcone, Acetyl Tetrapeptide-5, and Dipeptide-2 in Cetearyl Olivate base. Reduces dark circles, eye bags, and puffiness. Warming sensation is normal due to microcirculation stimulation.
Caffeine, Maltodextrin, Acetyl Tetrapeptide-5, Epigallocatechin Gallatyl Glucoside, Acetyl Tripeptide-1, Niacinamide, and Adenosine. Reduces dark circles, eye bags, and puffiness. Lightweight gel.
Copper Tripeptide-1, Acetyl Tetrapeptide-3, Myristoyl Pentapeptide-17, Myristoyl Hexapeptide-16, and Biotinyl Tripeptide-1. Apply with brush to lash base and brow. Results visible within 2–4 weeks.
Target SPF 30. C12-13 Alkyl Benzoate organic UV filters with Copper Tripeptide-1 and Gardenia Jasminoides Fruit Extract. UV protection that improves skin health. Easy wash-off. Apply after moisturizer.
Target SPF 40. Isododecane mineral base with Lauryl PEG-10, Copper Tripeptide-1, and Gardenia Jasminoides Fruit Extract. Water resistant. Apply after moisturizer.
Pentapeptide-18, Sodium Hyaluronate, Copper Tripeptide-1, Dipeptide Diaminobutyroyl Benzylamide Diacetate, Acetyl Hexapeptide-8 and -30. Reduces muscle contraction, wrinkles, and smooths. For commercial formulating — not consumer direct use.
Formulation Bases
Capric/Caprylic Triglycerides, Glycerin, Isopropyl Palmitate, Cetearyl Alcohol, Ceteareth-20 and -25, Dimethicone. Clean, versatile base designed to accommodate the addition of active ingredients. Instructions determined by formulator.
Capric/Caprylic Triglyceride with Cetearyl Olivate, Sorbitan Olivate, Squalane, Bisabolol, Ceramides NP, AP, EOP, AS, NS, Phytosphingosine, and Cholesterol. Rich ceramide base for barrier-supporting formulations.
Glycerin, Squalane, and Polyglyceryl-10 Stearate in a lightweight nano-emulsion. For the addition of active ingredients. Sulfate-free, alcohol-free, vegan, paraben-free.
Glycerin, Polyacrylates Crosspolymer-6, and Gardenia Jasminoides Fruit Extract. Lightweight serum base for active ingredient delivery. Oil-free, alcohol-free, vegan, paraben-free.
Propanediol, Glycerin, 1,2-Hexanediol, Phenoxyethanol, and Palmitoyl Tripeptide-8. Ultra-concentrated ampoule format for high-potency active ingredient delivery. Oil-free, alcohol-free, vegan, paraben-free.
Category 09 · 2026 Catalog
Metabolic, cognitive, longevity, and healing compounds in oral tablet and capsule form. MOQ tiers from 100 to 2,500+ bottles.
32 SKUsMetabolic & Weight Management
NNMT inhibitor for fat cell reduction, metabolic enhancement, and NAD+ pathway activation. High-strength 100mg tablet. 5-tier MOQ: 100 / 250 / 500 / 1000 / 2500+.
Lower-dose oral NNMT inhibitor options. 30mg and 50mg tablets in 60-count bottles for metabolic enhancement and NAD+ pathway activation. Full 5-tier MOQ structure.
Dual metabolic stack combining NNMT inhibition (5-Amino-1MQ) with SLU-PP-332 ERRα/γ agonism for synergistic fat oxidation and exercise-mimetic effects.
Oral hGH C-terminal fragment. Targets fat metabolism without growth-promoting or insulin-disrupting effects. 500mcg tablets, 60 count. 5-tier MOQ.
Oral GLP-1 receptor agonist semaglutide at 3mg and 5mg strengths. 30 tablets per bottle. Progressive dosing for metabolic management. Full 5-tier MOQ.
Oral GLP-1 receptor agonist at 7mg, 30 tablets per bottle. Full 5-tier MOQ tier structure (100 / 250 / 500 / 1000 / 2500+).
Dual stack combining oral GLP-1 receptor agonism with SLU-PP-332 ERR agonism for enhanced metabolic and fat-oxidation outcomes.
Combines oral GLP-1 receptor agonism with Tesofensine (triple monoamine reuptake inhibitor) for complementary appetite suppression and metabolic effects.
Oral non-peptide GLP-1 receptor agonist. 6mg tablets, 90 count per bottle — the largest count offering in the orals range. 5-tier MOQ structure.
ERRα/γ agonist — exercise-mimetic compound for fat oxidation, endurance enhancement, and metabolic improvement. Full strength and count range available. 5-tier MOQ.
Triple-compound metabolic and healing stack combining ERR agonism, NNMT inhibition, and BPC-157 gastroprotection. 90 count, 5-tier MOQ.
Triple monoamine reuptake inhibitor (serotonin, dopamine, noradrenaline) studied for appetite suppression and weight management. Available in 30ct and 60ct. Full 5-tier MOQ.
Metabolic and cognitive stack combining Tesofensine appetite suppression with Dihexa HGF receptor agonism for dual-pathway support. 60 count.
Mitochondrial electron carrier studied for cognitive enhancement, neuroprotection, mitochondrial function, and anti-aging. Available at 25mg/50ct and 10mg/60ct. Full 5-tier MOQ.
Healing & Gut Health
Oral BPC-157 at 500mcg per tablet. Studied for gut healing, tendon and ligament repair, anti-inflammatory effects, and neurological protection. Available in 30ct and 60ct. Full 5-tier MOQ.
Combines BPC-157 healing with KPV (α-MSH tripeptide) anti-inflammatory and gut-protecting effects. 60 count. Synergistic gut and inflammatory support.
Classic BPC-157 + TB-500 synergistic repair stack in oral form. Local healing cascade (BPC-157) and systemic tissue remodeling (TB-500). 60 count, full 5-tier MOQ.
Vasoactive Intestinal Peptide combined with BPC-157. VIP is studied for gut motility, immune regulation, and anti-inflammatory effects — complementary to BPC-157's healing profile.
Longevity, Cognitive & Anti-Aging
Oral telomerase-activating tetrapeptide (Ala-Glu-Asp-Gly). 3mg per tablet, 60 count. Studied for telomere elongation, circadian regulation, and lifespan extension. Full 5-tier MOQ.
Oral copper tripeptide for wound healing, collagen synthesis, antioxidant effects, and neuroprotection. 2mg per tablet, 60 count. Full 5-tier MOQ.
HGF/Met receptor agonist studied for cognitive enhancement, neurogenesis, and synaptic density improvement. Three strength options: 8mg, 10mg, 30mg — 30 count each. Full 5-tier MOQ.
Triple cognitive and healing stack: Dihexa neurogenesis, Tesofensine monoamine reuptake inhibition, and BPC-157 gut and tissue healing. 60 count, full 5-tier MOQ.